VIR:NASDAQ, Vir Biotechnology, Inc.

VIR stock overview

Vir Biotechnology, Inc. (VIR:NASDAQ) closed at $9.96 on October 16, 2026, down 4.87% on the day. The stock trades 17.0% below its 52-week high of $12.00 and 106.9% above its 52-week low of $4.82. Over the past year, it gained 72.3%. Vir Biotechnology, Inc. is part of the Health Care sector.

Key figures

Price
$9.96
Day change
-4.87%
Volume
1,735,243
Average volume
1,936,779
Market cap
1B+
52-week range
$4.82 – $12.00
50-day average
$10.55
200-day average
$9.25

Performance

5D 1M 3M 6M 1Y
-11.86% -8.79% +7.91% -10.19% +72.32%

Price action over the past year

In 252 trading sessions since October 16, 2025, VIR closed higher on 126 days (50%). Its best day was February 24, 2026 (+27.73%) and its worst was May 7, 2026 (-9.91%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

VIR news

About Vir Biotechnology, Inc.

Vir Biotechnology Inc is a clinical-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions.

Similar stocks

Find more stocks like VIR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.